Bevacizumab counteracts VEGF-dependent resistance to erlotinib in an EGFR-mutated NSCLC xenograft model.

Details

Language :

English

ISSN :

10196439

Volume :

51

Issue :

2

Database :

Complementary Index

Journal :

International Journal of Oncology

Publication Type :

Academic Journal

Accession number :

124841574

Full Text :

https://doi.org/10.3892/ijo.2017.4036